Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

miR-23b-3p rescues cognition in Alzheimer’s disease by reducing tau phosphorylation and apoptosis via GSK-3β signaling pathways
Hailun Jiang, Jianghong Liu, Shuilong Guo, et al.
Molecular Therapy — Nucleic Acids (2022) Vol. 28, pp. 539-557
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

A dual “turn-on” biosensor based on AIE effect and FRET for in situ detection of miR-125b biomarker in early Alzheimer's disease
Qin Zhang, Bohan Yin, Yingying Huang, et al.
Biosensors and Bioelectronics (2023) Vol. 230, pp. 115270-115270
Closed Access | Times Cited: 35
The miR-25802/KLF4/NF-κB signaling axis regulates microglia-mediated neuroinflammation in Alzheimer’s disease
Kaiyue Zhao, Jianghong Liu, Ting Sun, et al.
Brain Behavior and Immunity (2024) Vol. 118, pp. 31-48
Closed Access | Times Cited: 15
GSK3: A potential target and pending issues for treatment of Alzheimer's disease
Jiahui Zhao, Mengying Wei, Min‐Song Guo, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 7
Open Access | Times Cited: 15
Exosomes and non-coding RNAs: bridging the gap in Alzheimer’s pathogenesis and therapeutics
Chunhui Guo, You Yanqiu, Jibing Chen, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 1
Open Access | Times Cited: 1
miR‐32533 Reduces Cognitive Impairment and Amyloid‐β Overload by Targeting CREB5‐Mediated Signaling Pathways in Alzheimer's Disease
Li Zeng, Zhongdi Cai, Jianghong Liu, et al.
Advanced Science (2025)
Open Access | Times Cited: 1
MicroRNA-based recent research developments in Alzheimer's disease
Jaime Ramirez-Gomez, Sarthak Dalal, Davin Devara, et al.
Journal of Alzheimer s Disease (2025)
Closed Access | Times Cited: 1
Delivering miR-23b-3p by small extracellular vesicles to promote cell senescence and aberrant lipid metabolism
Ye Jin, Gaoge Sun, B Chen, et al.
BMC Biology (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Potential Implications of miRNAs in the Pathogenesis, Diagnosis, and Therapeutics of Alzheimer’s Disease
Long Wang, Xindong Shui, Yuelin Diao, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16259-16259
Open Access | Times Cited: 22
Epigenetic modifications of DNA and RNA in Alzheimer’s disease
Paula Martínez-Feduchi, Peng Jin, Bing Yao
Frontiers in Molecular Neuroscience (2024) Vol. 17
Open Access | Times Cited: 7
MicroRNA Networks in Cognition and Dementia
Grace S. Blount, Layton Coursey, Jannet Kocerha
Cells (2022) Vol. 11, Iss. 12, pp. 1882-1882
Open Access | Times Cited: 27
Febuxostat alleviates Arsenic Trioxide-Induced renal injury in Rats: Insights on the crosstalk between NLRP3/TLR4, Sirt-1/NF-κB/TGF-β signaling Pathways, and miR-23b-3p, miR-181a-5b expression
Basel A. Abdel‐Wahab, Ehab A. M. El‐Shoura, Mohammed Shafiuddin Habeeb, et al.
Biochemical Pharmacology (2023) Vol. 216, pp. 115794-115794
Closed Access | Times Cited: 16
Human Breast Milk microRNAs, Potential Players in the Regulation of Nervous System
Luis Freiría‐Martínez, Marta Iglesias‐Martínez‐Almeida, Cynthia Rodríguez-Jamardo, et al.
Nutrients (2023) Vol. 15, Iss. 14, pp. 3284-3284
Open Access | Times Cited: 14
Neuroprotection and Mechanism of Gas-miR36-5p from Gastrodia elata in an Alzheimer’s Disease Model by Regulating Glycogen Synthase Kinase-3β
Zhongteng Lu, Jianyuan Fu, Guang Wu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17295-17295
Open Access | Times Cited: 14
Exploring small non-coding RNAs as blood-based biomarkers to predict Alzheimer’s disease
Laia Gutiérrez-Tordera, Christopher Papandreou, Nil Novau-Ferré, et al.
Cell & Bioscience (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
The role of ATP‐binding cassette transporter G1 (ABCG1) in Alzheimer's disease: A review of the mechanisms
Mohsen Karbasi Yazdi, Mohaddeseh Sadat Alavi, Ali Roohbakhsh
Basic & Clinical Pharmacology & Toxicology (2024) Vol. 134, Iss. 4, pp. 423-438
Open Access | Times Cited: 6
Could protein phosphatase 2A and glycogen synthase kinase-3 beta be targeted by natural compounds to ameliorate Alzheimer’s pathologies?
Sushmitaa Dhevii Manoharan, Hafizah Abdul Hamid, Nur Fariesha Md Hashim, et al.
Brain Research (2024) Vol. 1829, pp. 148793-148793
Closed Access | Times Cited: 5
Cerebrospinal fluid microRNAs as potential biomarkers in Alzheimer’s disease
Ahmed Noor Eddin, Khaled Hamsho, Ghaith Adi, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 12
Mesenchymal Stem Cells from Familial Alzheimer’s Patients Express MicroRNA Differently
Lory Jhenifer Rochín-Hernández, Lory Sthephany Rochín-Hernández, Mayte Lizeth Padilla-Cristerna, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1580-1580
Open Access | Times Cited: 4
The role of Phosphodiesterase-1 and its natural product inhibitors in Alzheimer’s disease: A review
Nazir Ahmad, Kaisun Nesa Lesa, Ari Sudarmanto, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 17
Role of traditional Chinese medicine in ameliorating mitochondrial dysfunction via non-coding RNA signaling: Implication in the treatment of neurodegenerative diseases
Zhongdi Cai, Mimin Liu, Li Zeng, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 10
Pathogenesis of miR-155 on nonmodifiable and modifiable risk factors in Alzheimer’s disease
Jiajia Liu, Yun-fan Long, Peng Xu, et al.
Alzheimer s Research & Therapy (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Neuroprotective Mechanisms of Salidroside in Alzheimer’s Disease: A Systematic Review and Meta-analysis of Preclinical Studies
Nan Zhang, Jianfei Nao, Xiaoyu Dong
Journal of Agricultural and Food Chemistry (2023) Vol. 71, Iss. 46, pp. 17597-17614
Closed Access | Times Cited: 10
Progress in the study of anti-Alzheimer's disease activity of pyrimidine-containing bioactive molecules
Yulin Liu, Qian Zhang, Bingqian Li, et al.
European Journal of Medicinal Chemistry (2025) Vol. 285, pp. 117199-117199
Closed Access
Network pharmacology exploring the mechanistic role of indirubin phytoconstituent from Indigo naturalis targeting GSK-3 β in Alzheimer’s disease
Hitesh Kumar, Ashok Kumar Datusalia, Anoop Kumar, et al.
Journal of Biomolecular Structure and Dynamics (2025), pp. 1-14
Closed Access
GSK-3β dysregulation in aging: Implications for tau pathology and Alzheimer's disease progression
Arcot Rekha, Muhammad Afzal, M. Arockia Babu, et al.
Molecular and Cellular Neuroscience (2025), pp. 104005-104005
Closed Access
Page 1 - Next Page

Scroll to top